BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24158079)

  • 1. The case of a patient affected by primary gliosarcoma and neuroendocrine pancreatic cancer with prolonged survival.
    Trignani M; Taraborrelli M; Ausili Cèfaro G
    Tumori; 2013; 99(3):e117-9. PubMed ID: 24158079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
    Kalita O; Zlevorová M; Megová M; Vaverka M; Trojanec R; Tučková L
    Klin Onkol; 2016; 29(6):454-459. PubMed ID: 27951723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review.
    Szymanowski B; Duchnowska R; Bilski M; Łapińska G; Hryciuk B; Kamiński G; Szczylik C
    Nucl Med Rev Cent East Eur; 2016; 19(1):54-7. PubMed ID: 26838946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Tumors.
    Basuroy R; Srirajaskanthan R; Ramage JK
    Gastroenterol Clin North Am; 2016 Sep; 45(3):487-507. PubMed ID: 27546845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
    Butowski N; Chang SM; Lamborn KR; Polley MY; Pieper R; Costello JF; Vandenberg S; Parvataneni R; Nicole A; Sneed PK; Clarke J; Hsieh E; Costa BM; Reis RM; Hristova-Kazmierski M; Nicol SJ; Thornton DE; Prados MD
    Neuro Oncol; 2011 Dec; 13(12):1331-8. PubMed ID: 21896554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic neuroendocrine neoplasms.
    Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
    Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
    Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliosarcoma: a clinical and radiological analysis of 48 cases.
    Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X
    Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of endocrine gastroenteropancreatic tumors.
    Tomassetti P; Campana D; Nori F; Piscitelli L; Salomone L; Pezzilli R; Corinaldesi R
    JOP; 2006 Jan; 7(1):145-9. PubMed ID: 16407637
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
    Cloyd JM; Poultsides GA
    World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cases in the Management of NETs: Focus on Sequencing Somatostatin Analogs.
    Iyer R
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):4-7. PubMed ID: 27167991
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
    Baur AD; Pavel M; Prasad V; Denecke T
    Acta Radiol; 2016 Mar; 57(3):260-70. PubMed ID: 25855665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary gliosarcoma with extra-cranial metastases: a report and review of the literature.
    Dawar R; Fabiano AJ; Qiu J; Khushalani NI
    Clin Neurol Neurosurg; 2013 Apr; 115(4):375-80. PubMed ID: 22795300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies.
    Vaghaiwalla T; Ruhle B; Memeh K; Angelos P; Kaplan E; Liao CY; Polite B; Keutgen X
    Surgery; 2021 Jan; 169(1):162-167. PubMed ID: 32446596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in treatment of pancreatic neuroendocrine tumors].
    Imamura M
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):143-6. PubMed ID: 18536317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of diagnosis and management of neuroendocrine tumours.
    Raphael MJ; Chan DL; Law C; Singh S
    CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
    [No Abstract]   [Full Text] [Related]  

  • 17. Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report.
    Tremmel T; Holland-Cunz S; Günther P
    J Med Case Rep; 2015 Oct; 9():230. PubMed ID: 26438383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses.
    de Herder WW; Lamberts SW
    Curr Opin Oncol; 2002 Jan; 14(1):53-7. PubMed ID: 11790981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliosarcoma associated with a huge cyst--case report.
    Kurosaki M; Taniura S; Tanaka S; Takenobu A; Watanabe T; Horie Y
    Neurol Med Chir (Tokyo); 2000 Nov; 40(11):581-4. PubMed ID: 11109796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
    Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
    Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.